In this manuscript we demonstrate, that IFN-γ-mediated induction of programmed death ligand 1 (PD-L1) on human monocyte-derived dendritic cells (DCs) represents an important tolerogenic aspect in immunological network of type II IFNs. When fully differentiated, immature DCs were treated with ...
Programmed Death Ligand 1 Programmed death ligand 1 (PD-L1; and its partner PD-L2) is atransmembrane proteinexpressed in normal tissues to inhibit the activity of T-cells and prevent autoimmunity. PD-L1 is commonly upregulated on the surface of tumor cells, binding to the programmed death 1...
程序性死亡配体1(PDL-1)/ CD274英文名字 Programmed Death Ligand-1 (PDL-1) / CD274供应商 Anogen产品货号 MO-L40044O-0.5 mg产品报价 ￥已停产产品说明书 点击查看购买方式 银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868。产品新闻...
6) Programmed death 1 ligant 1(PD-L1) 程序性死亡因子1配体1补充资料:异配位体配位化合物 分子式:CAS号:性质:又称异配位体配位化合物。中心离子同时与两种以上不同配体共存于配位内界所组成的单核或多核配位化合物。例如,三氯·氨合铂(II)酸钾和(2)铜(II)-吡啶(py)-水杨酸(sal)配位化合物。在...
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study. Journal for immunotherapy of cancer. 2015; 3:3. [PubMed: 25767716]Fay AP, Signoretti S, Callea M, Telomicron GH, McKay RR, Song J, Carvo I, Lampron ME, Kaymakcalan MD, Poli-de-Figueiredo CE...
Programmed death-ligand 1 (PD-L1) protein. Produced by tumor to suppress the immune system. Blockers of the PD-L1 and PD-1 interaction are an important new anticancer drug class. ,站酷海洛,一站式正版视觉内容平台,站酷旗下品牌.授权内容包含正版商业图片、艺
产品名称:Programmed cell death 1 ligand 1 ELISA Kit 检测范围:0.156-10 ng/mL 保存条件:2-8℃低温保存 保质期:6个月,所有试剂盒均提供批次。 试剂盒成分:酶标板,试剂,标准品等。 选型: 产品规格:96T/48T 96T指可以做94个标本-2个标准对照-84个样本 ...
Anti-B7-H1/PDL1/CD274(programmed death ligand 1) 克隆鼠单抗的可变区基因,可从基因组文库中分离,也可用PCR技术分离。 人抗体恒定区可根据需要选择,不同的恒定区会带给嵌合抗体不同功能。为避免人抗体的恒定区产生不需要的副作用,可通过点突变来修饰调整其效应。
6) Programmed death 1 ligant 1(PD-L1) 程序性死亡因子1配体1补充资料:异配位体配位化合物 分子式:CAS号:性质:又称异配位体配位化合物。中心离子同时与两种以上不同配体共存于配位内界所组成的单核或多核配位化合物。例如,三氯·氨合铂(II)酸钾和(2)铜(II)-吡啶(py)-水杨酸(sal)配位化合物。在...
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial Pembrolizumab improved survival as first- and second-line therapy compared with chemotherapy in patients with highly programmed death ligand 1 (PD-L1) expr... R Hui,EB Garo...